Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Unravelling the role of gut microbiota in Parkinson’s disease progression: Pathogenic and therapeutic implications
Linchi Rani, Amal Chandra Mondal
Neuroscience Research (2021) Vol. 168, pp. 100-112
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
Bruna Araújo, Rita Caridade-Silva, Carla Guedes, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2908-2908
Open Access | Times Cited: 83
Overlapping Mechanisms of Action of Brain-Active Bacteria and Bacterial Metabolites in the Pathogenesis of Common Brain Diseases
Tanja Patricia Eicher, M. Hasan Mohajeri
Nutrients (2022) Vol. 14, Iss. 13, pp. 2661-2661
Open Access | Times Cited: 80
Air Pollution and the Risk of Parkinson's Disease: A Review
Hiromi Murata, Lisa M. Barnhill, Jeff M. Bronstein
Movement Disorders (2022) Vol. 37, Iss. 5, pp. 894-904
Open Access | Times Cited: 71
Impact of the mother's gut microbiota on infant microbiome and brain development
Eman A. Mady, Ahmed S. Doghish, Walaa A. El‐Dakroury, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 150, pp. 105195-105195
Closed Access | Times Cited: 52
Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer’s and Parkinson’s disease
Niklas Reich, Christian Hölscher
Frontiers in Neuroendocrinology (2024) Vol. 73, pp. 101122-101122
Open Access | Times Cited: 16
Pathophysiology linking depression and type 2 diabetes: Psychotherapy, physical exercise, and fecal microbiome transplantation as damage control
Rhea Subba, Rajat Sandhir, Surya Pratap Singh, et al.
European Journal of Neuroscience (2021) Vol. 53, Iss. 8, pp. 2870-2900
Closed Access | Times Cited: 43
Gut–Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson’s Disease
Elizabeth Riegelman, Kathy S. Xue, Jia-Sheng Wang, et al.
Nutrients (2024) Vol. 16, Iss. 13, pp. 2041-2041
Open Access | Times Cited: 7
A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson’s disease
Büşra Aktaş, Belma Aslım, Deniz Ateş
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review)
Qingchun Lei, Tingting Wu, Jin Wu, et al.
Molecular Medicine Reports (2021) Vol. 24, Iss. 4
Open Access | Times Cited: 37
Novel Pharmacotherapies in Parkinson’s Disease
Yousef Tizabi, Bruk Getachew, Michael Aschner
Neurotoxicity Research (2021) Vol. 39, Iss. 4, pp. 1381-1390
Open Access | Times Cited: 34
Comprehensive Review on Potential Signaling Pathways Involving the Transfer of α-Synuclein from the Gut to the Brain That Leads to Parkinson’s Disease
Shobha Kumari, Rajeev Taliyan, Sunil Kumar Dubey
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 4, pp. 590-602
Closed Access | Times Cited: 15
The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson’s disease
Qing Li, Ling‐bing Meng, Lijun Chen, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 15
Traffic-related air pollution and Parkinson's disease in central California
Dayoon Kwon, Kimberly C. Paul, Yu Yu, et al.
Environmental Research (2023) Vol. 240, pp. 117434-117434
Open Access | Times Cited: 14
Neuroprotective and Immunomodulatory Effects of Probiotics in a Rat Model of Parkinson’s Disease
Irving Parra, Isabel Martínez‐Alcalá, Lizbeth Vásquez-Celaya, et al.
Neurotoxicity Research (2023) Vol. 41, Iss. 2, pp. 187-200
Closed Access | Times Cited: 13
The Effects of Air Pollution on Neurological Diseases: A Narrative Review on Causes and Mechanisms
Margaret J. Lane, Eleise Oyster, Yali Luo, et al.
Toxics (2025) Vol. 13, Iss. 3, pp. 207-207
Open Access
Intestinal dysbiosis leads to the reduction in neurochemical production in Parkinson’s disease (PD)
Rahul Kumar, Rahul Kumar
International review of neurobiology (2025)
Closed Access
Microbiome Changes in Humans with Parkinson’s Disease after Photobiomodulation Therapy: A Retrospective Study
Brian Bicknell, Ann Liebert, Craig S. McLachlan, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 1, pp. 49-49
Open Access | Times Cited: 21
One Giant Leap from Mouse to Man: The Microbiota–Gut–Brain Axis in Mood Disorders and Translational Challenges Moving towards Human Clinical Trials
Sofia D. Forssten, Arthur C. Ouwehand, Síle M. Griffin, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 568-568
Open Access | Times Cited: 21
Gut Microbial Alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent
Büşra Aktaş
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2815-2829
Open Access | Times Cited: 12
The gut microbiome: an important role in neurodegenerative diseases and their therapeutic advances
Songlin Li, Linna Zhao, Jie Xiao, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 9, pp. 2217-2243
Closed Access | Times Cited: 12
The Brain–Gut–Bone Axis in Neurodegenerative Diseases: Insights, Challenges, and Future Prospects
Rong Li, Zong Miao, Yue Liu, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 4
The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson’s Disease
Liyan Yao, Yong Yang, Xiaowei Yang, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 9078-9109
Closed Access | Times Cited: 3
Agathobaculum butyriciproducens Shows Neuroprotective Effects in a 6-OHDA-Induced Mouse Model of Parkinson’s Disease
Da Woon Lee, Young‐Kyoung Ryu, Dong‐Ho Chang, et al.
Journal of Microbiology and Biotechnology (2022) Vol. 32, Iss. 9, pp. 1168-1177
Open Access | Times Cited: 14
Multidirectional associations between the gut microbiota and Parkinson’s disease, updated information from the perspectives of humoral pathway, cellular immune pathway and neuronal pathway
Xiaokang Jia, Qiliang Chen, Yuanyuan Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
The Neurodegenerative Elderly Syndrome (NES) hypothesis: Alzheimer and Parkinson are two faces of the same disease
Daniele Caligiore, Flora Giocondo, Massimo Silvetti
IBRO Neuroscience Reports (2022) Vol. 13, pp. 330-343
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top